| __timestamp | Galapagos NV | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 1213000 |
| Thursday, January 1, 2015 | 20309000 | 3425000 |
| Friday, January 1, 2016 | 16945000 | 6311000 |
| Sunday, January 1, 2017 | 20559000 | 9518000 |
| Monday, January 1, 2018 | 29641000 | 28080000 |
| Tuesday, January 1, 2019 | 88258000 | 36550000 |
| Wednesday, January 1, 2020 | 162170000 | 46125000 |
| Friday, January 1, 2021 | 167218000 | 68486000 |
| Saturday, January 1, 2022 | 239528000 | 92032000 |
| Sunday, January 1, 2023 | 94252000 | 117532000 |
Unleashing the power of data
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Galapagos NV and Rhythm Pharmaceuticals, Inc. have showcased contrasting SG&A spending patterns.
From 2014 to 2023, Galapagos NV's SG&A expenses surged by over 900%, peaking in 2022. This consistent increase reflects their aggressive expansion strategy and commitment to scaling operations.
In contrast, Rhythm Pharmaceuticals started with modest SG&A expenses, but by 2023, they had increased their spending by nearly 9,600%. This dramatic rise, especially post-2018, indicates a strategic pivot towards growth and market penetration.
These spending patterns highlight the diverse strategies employed by biotech firms to navigate the industry's challenges and opportunities.
Gilead Sciences, Inc. vs Rhythm Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Biogen Inc. and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV